Pieper Steven
Insider CIK 1875714 · XERS See Remarks · XERS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, | S Sale | 2026-10-01 | 2026-10-02 | 5,000 | $9.41 | $47.0K | 1,351,053 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-09-01 | 2026-09-01 | 5,000 | $8.50 | $42.5K | 1,356,053 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-09-01 | 2026-09-01 | 5,000 | $8.50 | $42.5K | 1,356,053 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-08-12 | 2026-08-12 | 5,000 | $8.50 | $42.5K | 1,361,053 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-08-12 | 2026-08-12 | 5,000 | $8.50 | $42.5K | 1,361,053 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-07-07 | 2026-07-07 | 27,600 | $8.52 | $235.2K | 1,366,053 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-07-06 | 2026-07-07 | 17,400 | $8.50 | $147.9K | 1,393,653 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2026-03-05 | 2026-03-05 | 14,036 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2026-03-05 | 2026-03-05 | 27,891 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2026-03-05 | 2026-03-05 | 27,891 | $4.09 | $114.1K | 1,394,904 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2026-03-05 | 2026-03-05 | 14,036 | $5.93 | $83.2K | 1,408,940 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 111,765 | $7.36 | $822.6K | 1,460,782 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 66,450 | $7.36 | $489.1K | 1,394,332 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 27,319 | $7.36 | $201.1K | 1,367,013 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2026-01-30 | 2026-02-02 | 207,207 | — | $0 | 207,207 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2026-01-30 | 2026-02-02 | 154,986 | — | $0 | 1,572,547 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2025-01-31 | 2025-02-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2025-01-31 | 2025-02-03 | 185,000 | — | $0 | 1,417,561 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 110,750 | $3.56 | $394.3K | 1,299,011 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 66,450 | $3.56 | $236.6K | 1,232,561 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-03 | 2025-01-07 | 32,059 | $3.61 | $115.7K | 1,409,761 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2024-11-22 | 2024-11-26 | 2,640 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2024-11-22 | 2024-11-26 | 16,843 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2024-11-22 | 2024-11-26 | 19,483 | $1.55 | $30.2K | 1,441,820 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-07-28 | 2024-08-09 | 14,767 | $2.61 | $38.5K | 1,422,337 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-31 | 2024-08-09 | 110,750 | $2.46 | $272.4K | 1,437,104 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-01-31 | 2024-01-31 | 450,000 | — | $0 | 1,626,912 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-29 | 2024-08-09 | 4,379 | $2.66 | $11.6K | 1,547,854 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-03 | 2024-08-09 | 23,067 | $2.24 | $51.7K | 1,552,233 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2023-11-20 | 2023-11-21 | 28,000 | $1.95 | $54.6K | 1,176,912 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-07-28 | 2024-08-09 | 10,200 | $2.53 | $25.8K | 1,575,300 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-31 | 2024-08-09 | 778 | $1.24 | $965 | 1,585,500 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2023-01-31 | 2023-02-01 | 750,000 | — | $0 | 1,148,912 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-29 | 2024-08-09 | 3,590 | $1.26 | $4.5K | 1,586,278 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-03 | 2024-08-09 | 23,067 | $1.12 | $25.8K | 1,589,868 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-07-28 | 2024-08-09 | 9,767 | $1.43 | $14.0K | 1,612,935 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-01-31 | 2024-08-09 | 750 | $2.11 | $1.6K | 1,622,702 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-01-29 | 2024-08-09 | 3,460 | $2.11 | $7.3K | 1,623,452 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-01-03 | 2022-01-05 | 200,000 | — | $0 | 388,834 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2021-11-10 | 2021-11-12 | 25,000 | $2.00 | $50.0K | 183,108 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 27,891 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 12,500 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 14,036 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 2,640 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 16,843 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 14,036 | — | $0 | 14,036 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 16,843 | — | $0 | 16,843 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 2,640 | — | $0 | 2,640 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 27,891 | — | $0 | 27,891 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 134,333 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 23,775 | — | $0 | 134,333 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 134,333 | — | $0 | 158,108 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 23,775 | — | $0 | 23,775 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2021-07-28 | 2021-07-29 | 100,000 | — | $0 | 158,858 | SEC↗ |